Ulcerative Colitiis
Showing 1 - 25 of 1,203
Ulcerative Colitis, Postoperative Complications, Ileal Pouch Trial in Nanjing (TAMIS-IPAA, Lap-IPAA)
Unknown status
- Ulcerative Colitis
- +2 more
- TAMIS-IPAA
- Lap-IPAA
-
Nanjing, Jiangsu, ChinaDepartment of Generay Surgery, Jinling hosptal, Medical School o
May 15, 2018
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
Not yet recruiting
- Ulcerative Colitis
- (no location specified)
Nov 20, 2023
Ulcerative Colitis Trial (HRV biofeedback)
Not yet recruiting
- Ulcerative Colitis
- HRV biofeedback
- (no location specified)
May 28, 2023
Ulcerative Colitis Trial in Malatya (Mediterranean Diet, Curcumin Supplementation, Resveratrol Supplementation)
Recruiting
- Ulcerative Colitis
- Mediterranean Diet
- +2 more
-
Malatya, Turkey
- +1 more
Mar 7, 2023
Ulcerative Colitis Trial in Kissimmee (Rosnilimab, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Rosnilimab
- Placebo
-
Kissimmee, FloridaAnaptysBio Investigative Site 10-101
Nov 7, 2023
Ulcerative Colitis Trial in Xi'an (G132 system, Beijing PINS Medical Co., China)
Not yet recruiting
- Ulcerative Colitis
- G132 system, Beijing PINS Medical Co., China
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jun 8, 2023
Assess Safety of Ozanimod in Moderate to Severe Active UC in
Not yet recruiting
- Ulcerative Colitis
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Upper Endoscopy in Ulcerative Colitis Assiut University
Not yet recruiting
- Upper Gastrointestinal Disorder
- Upper endoscopy
- (no location specified)
Oct 19, 2023
Ulcerative Colitis Trial (Oncostatin M)
Not yet recruiting
- Ulcerative Colitis
- Oncostatin M
- (no location specified)
Jul 26, 2023
Colitis, Ulcerative Trial in Worldwide (Spesolimab IV infusion, Spesolimab SC solution for injection)
Active, not recruiting
- Colitis, Ulcerative
- Spesolimab IV infusion
- Spesolimab SC solution for injection
-
Hamden, Connecticut
- +37 more
Jan 23, 2023
Ulcerative Colitis Trial (NX-13 250mg, NX-13 750mg, NX-13 Placebo)
Not yet recruiting
- Ulcerative Colitis
- NX-13 250mg
- +2 more
- (no location specified)
Mar 28, 2023
Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate Trial in Worldwide (Ulcerative colitis
Not yet recruiting
- Ulcerative Colitis
- +2 more
- Ulcerative colitis Exclusion Diet
- +3 more
-
Afula, Israel
- +5 more
Mar 16, 2023
Colitis, Ulcerative, IBD Trial in Worldwide (Placebo IV, Placebo SC, Ustekinumab IV)
Completed
- Colitis, Ulcerative
- Inflammatory Bowel Diseases
- Placebo IV
- +3 more
-
Birmingham, Alabama
- +253 more
Jan 3, 2023
Ulcerative Colitis Trial (Roflumilast 500 Ug ORAL TABLET [Daliresp], corticosteroids +immune suppressive +amino salicylic acid)
Not yet recruiting
- Ulcerative Colitis
- Roflumilast 500 Ug ORAL TABLET [Daliresp]
- corticosteroids +immune suppressive +amino salicylic acid
- (no location specified)
Jan 13, 2023
Ulcerative Colitis Trial in Izmir (Progressive Muscle Relaxation, Relaxative Music)
Active, not recruiting
- Ulcerative Colitis
- Progressive Muscle Relaxation
- Relaxative Music
-
Izmir, TurkeyEge University Faculty of Nursing
Mar 15, 2023
Ulcerative Colitis, IBD Trial in Oslo (IDOFORM®Travel)
Recruiting
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- IDOFORM®Travel
-
Oslo, NorwayOslo University Hospital
Sep 20, 2022
Ulcerative Colitis Trial (Mirikizumab IV, Mirikizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Mirikizumab IV
- Mirikizumab SC
- (no location specified)
Mar 24, 2023
Disease Activity and Adverse Events of Rinvoq in Adult Moderate
Recruiting
- Ulcerative Colitis
-
Kurume-shi, Fukuoka, Japan
- +4 more
Mar 17, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023
Ulcerative Colitis Trial in Worldwide (Placebo, Guselkumab)
Active, not recruiting
- Ulcerative Colitis
- Placebo
- Guselkumab
-
Lancaster, California
- +390 more
Jan 17, 2023
Mild to Moderate Ulcerative Colitis Trial in Guangzhou, Wuhan (SPH3127 Tablets with Dose A, SPH3127 Tablets with Dose B, SPH3127
Not yet recruiting
- Mild to Moderate Ulcerative Colitis
- SPH3127 Tablets with Dose A
- +2 more
-
Guangzhou, Guangdong, China
- +1 more
Mar 17, 2023